Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies-Reference-Cited by-同舟云学术

Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies

Published:2013-02-21 Issue:3 Volume:28 Page:333-337
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Mattei P.L.¹,Corey K.C.²,Kimball A.B.³

Affiliation:

1. The Johns Hopkins Hospital; Baltimore MD USA

2. University of Massachusetts Medical School; Worcester MA USA

3. Massachusetts General Hospital; Harvard Medical School; Boston MA USA

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.12106/fullpdf

Reference49 articles.

1. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany;Augustin;Dermatology,2008

2. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization;Perrott;Physiol Behav,2000

3. The contribution of perceptions of stigmatisation to disability in patients with psoriasis;Richards;J Psychosom Res,2001

4. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin;Touw;Br J Dermatol,2001

5. Concordance of the Psoriasis Area Severity Index (PASI) and patient-reported outcomes in psoriasis treatment;Schafer;Eur J Dermatol,2010

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg?;Journal of Clinical Medicine;2024-09-04

2. Calidad de vida percibida por los pacientes con psoriasis tratados con inhibidores de interleucina 17 y 23;Farmacia Hospitalaria;2024-09

3. [Translated article] Perceived quality of life in patients with psoriasis treated with interleukin 17 or 23 inhibitors;Farmacia Hospitalaria;2024-09

4. An inulin-type polysaccharide from Atractylodis Macrocephalae Rhizoma can relieve psoriasis;International Journal of Biological Macromolecules;2024-09

5. Factors Associated with Anxiety, Depression, and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study;Brain Sciences;2024-08-27